Dry powder inhaled compound delivery for early pre-clinical in vivo efficacy studies
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-9255
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Dry powder inhaled compound delivery for early pre-clinical in vivo efficacy studies ; volume:10 ; number:1 ; day:14 ; month:8 ; year:2013 ; pages:1 ; date:8.2013
Journal of Inflammation ; 10, Heft 1 (14.8.2013), 1, 8.2013
- Creator
-
Ives, Robert
- Contributor
-
Butterfield, Lindsay
Farr, John
Bater, Shaun
Nials, Tony
Entwistle, Lewis
Ball, Doug
Hessel, Edith
SpringerLink (Online service)
- DOI
-
10.1186/1476-9255-10-S1-P36
- URN
-
urn:nbn:de:1111-2016073036819
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:55 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ives, Robert
- Butterfield, Lindsay
- Farr, John
- Bater, Shaun
- Nials, Tony
- Entwistle, Lewis
- Ball, Doug
- Hessel, Edith
- SpringerLink (Online service)
Other Objects (12)
Stalin kept his Powder Dry
Dry powder formulations of hyperimmune serum
Dry powder coating in additive manufacturing
Inhaled Dry Powder Formulation of Tamibarotene, a Broad‐Spectrum Antiviral against Respiratory Viruses Including SARS‐CoV‐2 and Influenza Virus
Development of microparticle - nanoparticle powder mixtures for the use in dry powder inhalers
Inter-compound and Intra-compound Global Sensitivity Analysis of a Physiological Model for Pulmonary Absorption of Inhaled Compounds
Projected changes in compound hot-dry events depend on the dry indicator considered
Recent advances in capsule-based dry powder inhaler technology
A review of formulations and preclinical studies of inhaled rifampicin for its clinical translation
Inhaled Surfactant in the treatment of accidental Talc Powder inhalation: a new case report
The safety and efficacy of inhaled dry powder mannitol as a bronchial provocation test for airway hyperresponsiveness: a phase 3 comparison study with hypertonic (4.5%) saline
Impact of the number of repeated inhalations and patient characteristics on the residual amount of inhaled laninamivir octanoate hydrate dry powder in pediatric patients with influenza
Stalin kept his Powder Dry
Dry powder formulations of hyperimmune serum
Dry powder coating in additive manufacturing
Inhaled Dry Powder Formulation of Tamibarotene, a Broad‐Spectrum Antiviral against Respiratory Viruses Including SARS‐CoV‐2 and Influenza Virus
Development of microparticle - nanoparticle powder mixtures for the use in dry powder inhalers
Inter-compound and Intra-compound Global Sensitivity Analysis of a Physiological Model for Pulmonary Absorption of Inhaled Compounds
Projected changes in compound hot-dry events depend on the dry indicator considered
Recent advances in capsule-based dry powder inhaler technology
A review of formulations and preclinical studies of inhaled rifampicin for its clinical translation
Inhaled Surfactant in the treatment of accidental Talc Powder inhalation: a new case report
The safety and efficacy of inhaled dry powder mannitol as a bronchial provocation test for airway hyperresponsiveness: a phase 3 comparison study with hypertonic (4.5%) saline
Impact of the number of repeated inhalations and patient characteristics on the residual amount of inhaled laninamivir octanoate hydrate dry powder in pediatric patients with influenza
Stalin kept his Powder Dry
Dry powder formulations of hyperimmune serum
Dry powder coating in additive manufacturing
Inhaled Dry Powder Formulation of Tamibarotene, a Broad‐Spectrum Antiviral against Respiratory Viruses Including SARS‐CoV‐2 and Influenza Virus
Development of microparticle - nanoparticle powder mixtures for the use in dry powder inhalers
Inter-compound and Intra-compound Global Sensitivity Analysis of a Physiological Model for Pulmonary Absorption of Inhaled Compounds
Projected changes in compound hot-dry events depend on the dry indicator considered
Recent advances in capsule-based dry powder inhaler technology
A review of formulations and preclinical studies of inhaled rifampicin for its clinical translation
Inhaled Surfactant in the treatment of accidental Talc Powder inhalation: a new case report
The safety and efficacy of inhaled dry powder mannitol as a bronchial provocation test for airway hyperresponsiveness: a phase 3 comparison study with hypertonic (4.5%) saline